Literature DB >> 30396029

Vascular permeability in the brain is a late pathogenic event during Rift Valley fever virus encephalitis in rats.

Aaron W Walters1, Michael R Kujawa1, Joseph R Albe1, Douglas S Reed2, William B Klimstra2, Amy L Hartman3.   

Abstract

Rift Valley fever virus (RVFV) is a zoonotic disease of livestock that causes several clinical outcomes in people including febrile disease, hemorrhagic fever, and/or encephalitis. After aerosol infection with RVFV, Lewis rats develop lethal encephalitic disease, and we use this as a model for studying disease mechanisms of RVFV infection in the brain. Permeability of the brain vasculature in relation to virus invasion and replication is not known. Here, we found that vascular permeability in the brain occurred late in the course of infection and corresponded temporally to expression of matrix metalloproteinase-9 (MMP-9). Virus replication was ongoing within the central nervous system for several days prior to detectable vascular leakage. Based on this study, vascular permeability was not required for entry of RVFV into the brain of rats. Prevention of vascular leakage late in infection may be an important component for prevention of lethal neurological disease in the rat model.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aerosol infection; Blood brain barrier; Rift valley fever; Viral encephalitis

Mesh:

Substances:

Year:  2018        PMID: 30396029      PMCID: PMC6286220          DOI: 10.1016/j.virol.2018.10.021

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  33 in total

Review 1.  Risk factors associated with human Rift Valley fever infection: systematic review and meta-analysis.

Authors:  Dennis E Nicholas; Kathryn H Jacobsen; Nigel M Waters
Journal:  Trop Med Int Health       Date:  2014-09-24       Impact factor: 2.622

2.  Aerosolized rift valley fever virus causes fatal encephalitis in african green monkeys and common marmosets.

Authors:  Amy L Hartman; Diana S Powell; Laura M Bethel; Amy L Caroline; Richard J Schmid; Tim Oury; Douglas S Reed
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

3.  Risk factors for severe Rift Valley fever infection in Kenya, 2007.

Authors:  Amwayi S Anyangu; L Hannah Gould; Shahnaaz K Sharif; Patrick M Nguku; Jared O Omolo; David Mutonga; Carol Y Rao; Edith R Lederman; David Schnabel; Janusz T Paweska; Mark Katz; Allen Hightower; M Kariuki Njenga; Daniel R Feikin; Robert F Breiman
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

4.  [Severe presentations of Rift Valley Fever in Madagascar].

Authors:  R A Rakotoarivelo; R Andrianasolo; S H Razafimahefa; N S Randremandranto Razafimbelo; M J D Randria
Journal:  Med Mal Infect       Date:  2011-02-03       Impact factor: 2.152

5.  Capillaries in the olfactory bulb but not the cortex are highly susceptible to virus-induced vascular leak and promote viral neuroinvasion.

Authors:  Clayton W Winkler; Brent Race; Katie Phillips; Karin E Peterson
Journal:  Acta Neuropathol       Date:  2015-05-09       Impact factor: 17.088

6.  Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor.

Authors:  Saguna Verma; Mukesh Kumar; Ulziijargal Gurjav; Stephanie Lum; Vivek R Nerurkar
Journal:  Virology       Date:  2009-11-18       Impact factor: 3.616

7.  Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain.

Authors:  Penghua Wang; Jianfeng Dai; Fengwei Bai; Kok-Fai Kong; Susan J Wong; Ruth R Montgomery; Joseph A Madri; Erol Fikrig
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

8.  Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics.

Authors:  Tariq A Madani; Yagob Y Al-Mazrou; Mohammad H Al-Jeffri; Amin A Mishkhas; Abdullah M Al-Rabeah; Adel M Turkistani; Mohammad O Al-Sayed; Abdullah A Abodahish; Ali S Khan; Thomas G Ksiazek; Osama Shobokshi
Journal:  Clin Infect Dis       Date:  2003-09-23       Impact factor: 9.079

9.  Serum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe disease.

Authors:  Petrus Jansen van Vuren; Sharon Shalekoff; Antoinette A Grobbelaar; Brett N Archer; Juno Thomas; Caroline T Tiemessen; Janusz T Paweska
Journal:  Virol J       Date:  2015-10-06       Impact factor: 4.099

10.  Severe Human Illness Caused by Rift Valley Fever Virus in Mauritania, 2015.

Authors:  Boushab Mohamed Boushab; Fatima Zahra Fall-Malick; Sidi El Wafi Ould Baba; Mohamed Lemine Ould Salem; Marie Roseline Darnycka Belizaire; Hamade Ledib; Mohamed Mahmoud Ould Baba Ahmed; Leonardo Kishi Basco; Hampaté Ba
Journal:  Open Forum Infect Dis       Date:  2016-09-27       Impact factor: 3.835

View more
  7 in total

1.  Development of Rift valley fever encephalitis in rats is mediated by early infection of olfactory epithelium and neuroinvasion across the cribriform plate.

Authors:  Devin A Boyles; Madeline M Schwarz; Joseph R Albe; Cynthia M McMillen; Katherine J O'Malley; Douglas S Reed; Amy L Hartman
Journal:  J Gen Virol       Date:  2021-02       Impact factor: 3.891

2.  Neutrophil and macrophage influx into the central nervous system are inflammatory components of lethal Rift Valley fever encephalitis in rats.

Authors:  Joseph R Albe; Devin A Boyles; Aaron W Walters; Michael R Kujawa; Cynthia M McMillen; Douglas S Reed; Amy L Hartman
Journal:  PLoS Pathog       Date:  2019-06-20       Impact factor: 6.823

Review 3.  The challenging management of Rift Valley Fever in humans: literature review of the clinical disease and algorithm proposal.

Authors:  Emilie Javelle; Alexandre Lesueur; Vincent Pommier de Santi; Franck de Laval; Thibault Lefebvre; Guillaume Holweck; Guillaume André Durand; Isabelle Leparc-Goffart; Gaëtan Texier; Fabrice Simon
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-01-22       Impact factor: 3.944

4.  Toll-like receptor 4 mediates blood-brain barrier permeability and disease in C3H mice during Venezuelan equine encephalitis virus infection.

Authors:  Bradley S Hollidge; Courtney A Cohen; Justice Akuoku Frimpong; Catherine V Badger; John M Dye; Connie S Schmaljohn
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 5.  Insights into the Pathogenesis of Viral Haemorrhagic Fever Based on Virus Tropism and Tissue Lesions of Natural Rift Valley Fever.

Authors:  Lieza Odendaal; A Sally Davis; Estelle H Venter
Journal:  Viruses       Date:  2021-04-20       Impact factor: 5.048

6.  Immune protection is dependent on the gut microbiome in a lethal mouse gammaherpesviral infection.

Authors:  Jordan R Yaron; Sriram Ambadapadi; Liqiang Zhang; Ramani N Chavan; Scott A Tibbetts; Shahar Keinan; Arvind Varsani; Juan Maldonado; Simona Kraberger; Amanda M Tafoya; Whitney L Bullard; Jacquelyn Kilbourne; Alison Stern-Harbutte; Rosa Krajmalnik-Brown; Barbara H Munk; Erling O Koppang; Efrem S Lim; Alexandra R Lucas
Journal:  Sci Rep       Date:  2020-02-11       Impact factor: 4.379

7.  Rift Valley Fever Virus Infection Causes Acute Encephalitis in the Ferret.

Authors:  Dominique J Barbeau; Joseph R Albe; Sham Nambulli; Natasha L Tilston-Lunel; Amy L Hartman; Seema S Lakdawala; Ed Klein; W Paul Duprex; Anita K McElroy
Journal:  mSphere       Date:  2020-10-28       Impact factor: 4.389

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.